ARTICLE | Clinical News
Dexisometheptene mucateg: Phase II started
June 29, 2015 7:00 AM UTC
Tonix began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate a single dose of 140 mg oral TNX-201 given when a tension-type headache occurs in about 200 patients. ...